Scott R. McDonnell
- Hepatology top 5%
- Oncology top 5%
-
- Lymphoma Diagnosis and Treatment 3
- Cancer Research top 10%
-
- Chronic Lymphocytic Leukemia Research 2
-
- Immune Cell Function and Interaction 2
-
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- Synthesis and bioactivity of alkaloids 1
-
- Child Nutrition and Feeding Issues 1
-
- Synthesis and biological activity 1
- Co-authors
- James G. ChristensenJoseph H. LeeGerrit LosGordon AltonBarbara MroczkowskiMaria E. ArangoQiuhua LiHelen Y. Zou
- Journals
- Oncogene (2 papers)Molecular Cancer Therapeutics (1 paper)American Journal of Physiology-Endocrinology and Metabolism (1 paper)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Scott R. McDonnell
12 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Hepatology 200
- Oncology 623
- Pulmonary and Respiratory Medicine 622
- Pathology and Forensic Medicine 250
- Cancer Research 209
Countries citing papers authored by Scott R. McDonnell
This map shows the geographic impact of Scott R. McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. McDonnell more than expected).
Fields of papers citing papers by Scott R. McDonnell
This network shows the impact of papers produced by Scott R. McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. McDonnell. The network helps show where Scott R. McDonnell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott R. McDonnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2021 | 12 | |
| 5 | 2017 | 24 | |
| 6 | 2016 | 14 | |
| 7 | 2013 | 57 | |
| 8 | 2011 | 29 | |
| 9 | 2010 | 64 | |
| 10 | 2008 | 22 | |
| 11 | An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanismsbreakdown → | 2007 | 593 |
| 12 | Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphomabreakdown → | 2007 | 513 |
| 13 | 2007 | 4 |
About Scott R. McDonnell
Scott R. McDonnell is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Immune Cell Function and Interaction (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), RNA modifications and cancer (2 papers), Synthesis and bioactivity of alkaloids (1 paper), Child Nutrition and Feeding Issues (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Hepatology (200 citations), Oncology (623 citations) and Pulmonary and Respiratory Medicine (622 citations). Scott R. McDonnell has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include James G. Christensen, Joseph H. Lee, Gerrit Los, Gordon Alton, Barbara Mroczkowski, Maria E. Arango, Qiuhua Li, Helen Y. Zou, Shinji Yamazaki and Mitchell D. Nambu. Their work appears in journals such as Oncogene, Molecular Cancer Therapeutics, American Journal of Physiology-Endocrinology and Metabolism, Molecular Therapy — Oncolytics and Molecular Genetics and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.